NL-OMON20650招募中不适用
Outcomes of patients with COVID-19 related cytokine release syndrome under immunosuppressive treatment
Zuyderland Medical Center0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Eligibility for immunosuppressive treatment is based on the Zuyderland treatment protocol (named; ‘Standpunt werkwijze behandeling COVID Zuyderland’, due to frequent updates will the most recent version be leading at any time).
- •According to Zuyderland treatment protocol version from 01.04.2020, this means:
- •1.Detection of diffuse interstitial pneumonia or bilateral infiltrations on chest x-ray or CO-RADS score =4 based on CT-thorax findings
- •2.Oxygen saturation at rest in ambient air = 94% or tachypnea =30/min.
- •3.Presence of at least 2 of the following risk factors for CRS
- •a.High ferritin (> 900 ug/L or two times the level at admission within 48 hours)
- •b.High C-reactive protein (> 100 mg/L)
- •c.High D-dimer (> 1500 ug/L)
排除标准
- •No specific exclusion criteria
研究者
相似试验
尚未招募
不适用
Assessment of Outcome in patients with COVID-19 using SOFA (Sequential Organ Failure Assessment) Score at PresentatioCTRI/2022/06/043388Maulana Azad Medical College
尚未招募
不适用
Effect of COVID-19 vaccination in Rheumatoid arthritis patientsCTRI/2021/09/036579AIIMS Bibnagar
尚未招募
不适用
â??Clinical profile and outcomes of COVID-19 patients admitted to an intensive care unit in a tertiary care hospitalâ??.CTRI/2021/03/031774Sri Ramachandra University
已完成
不适用
ongterm outcome of patients with COVID-19 associated akut respiratory distress syndrome (cARDS)COVID-19 and Follow-upLongCOVID DiseaseJ80.0DRKS00027856niversitätsklinikum Carl Gustav Carus184
尚未招募
不适用
C-Reactive Protein and COVID-19 PatientsCTRI/2021/11/038183il